Henan Lingrui Pharmaceutical Co Ltd (600285) — Cash Flow Reinvestment Rate
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥5.61 Million (capex CN¥5.61 Million ) from operating cash flow of CN¥140.12 Million. Explore Henan Lingrui Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Henan Lingrui Pharmaceutical Co Ltd across 26 annual periods. Also explore 600285 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Henan Lingrui Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600285 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥100.28 Million | CN¥553.88 Million | CN¥56.83 Million | ▼ -1.5% |
| 2024 | 0.18x | CN¥160.97 Million | CN¥875.86 Million | CN¥115.11 Million | ▼ -40.4% |
| 2023 | 0.31x | CN¥250.90 Million | CN¥813.43 Million | CN¥21.20 Million | ▲ +132.4% |
| 2022 | 0.13x | CN¥110.81 Million | CN¥834.91 Million | CN¥26.99 Million | ▼ -80.0% |
| 2021 | 0.66x | CN¥559.89 Million | CN¥845.69 Million | CN¥76.91 Million | ▲ +102.2% |
| 2020 | 0.33x | CN¥147.49 Million | CN¥450.53 Million | CN¥71.82 Million | ▼ -32.2% |
| 2019 | 0.48x | CN¥217.21 Million | CN¥450.15 Million | CN¥59.04 Million | ▼ -21.7% |
| 2018 | 0.62x | CN¥268.93 Million | CN¥436.25 Million | CN¥52.14 Million | ▼ -76.2% |
| 2017 | 2.59x | CN¥274.71 Million | CN¥105.97 Million | CN¥257.55 Million | ▼ -33.6% |
| 2016 | 3.90x | CN¥246.94 Million | CN¥63.26 Million | CN¥218.05 Million | ▲ +431.7% |
| 2015 | 0.73x | CN¥115.12 Million | CN¥156.82 Million | CN¥84.23 Million | ▼ -10.6% |
| 2014 | 0.82x | CN¥102.10 Million | CN¥124.32 Million | CN¥102.10 Million | ▼ -37.4% |
| 2013 | 1.31x | CN¥166.88 Million | CN¥127.27 Million | CN¥166.88 Million | ▼ -79.9% |
| 2012 | 6.51x | CN¥100.53 Million | CN¥15.43 Million | CN¥100.53 Million | ▲ +312.7% |
| 2011 | 1.58x | CN¥63.90 Million | CN¥40.49 Million | CN¥63.90 Million | ▲ +364.2% |
| 2009 | 0.34x | CN¥45.08 Million | CN¥132.61 Million | CN¥45.08 Million | ▼ -55.8% |
| 2008 | 0.77x | CN¥33.63 Million | CN¥43.72 Million | CN¥33.63 Million | ▼ -72.6% |
| 2007 | 2.81x | CN¥44.84 Million | CN¥15.99 Million | CN¥44.84 Million | ▲ +353.4% |
| 2006 | 0.62x | CN¥16.56 Million | CN¥26.76 Million | CN¥16.56 Million | ▲ +8.0% |
| 2005 | 0.57x | CN¥19.15 Million | CN¥33.43 Million | CN¥19.15 Million | ▼ -50.0% |
| 2004 | 1.14x | CN¥40.65 Million | CN¥35.51 Million | CN¥40.65 Million | ▼ -33.3% |
| 2003 | 1.72x | CN¥40.81 Million | CN¥23.79 Million | CN¥40.81 Million | ▲ +120.3% |
| 2002 | 0.78x | CN¥54.06 Million | CN¥69.41 Million | CN¥54.06 Million | ▼ -92.9% |
| 2001 | 10.93x | CN¥37.29 Million | CN¥3.41 Million | CN¥37.29 Million | ▲ +6.1% |
| 2000 | 10.31x | CN¥37.76 Million | CN¥3.66 Million | CN¥37.76 Million | ▲ +778.6% |
| 1999 | 1.17x | CN¥5.64 Million | CN¥4.81 Million | CN¥5.64 Million | — |